Latest stories on ALNY
Alnylam Pharmaceuticals Q2 2026 Earnings Preview
Seeking Alpha68 · bullishearnings
Why Alnylam’s Best Quarter Ever Didn’t Come With a Richer Valuation
Yahoo Finance54 · neutralgeneral
Alnylam to Webcast Conference Call Discussing Second Quarter 2026 Financial Results | ALNY Stock News
StockTitan50 · neutralgeneral
Alnylam Pharmaceuticals: Commercial Momentum Outweighs TTR Read-Through Concerns
Seeking Alpha67 · bullishproduct/pr
Morgan Stanley Raises its Price Target on Alnylam (ALNY)
Yahoo Top61 · neutralanalyst
The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions
MarketBeat34 · bearishproduct/pr
Alnylam Pharmaceuticals: An Unexpected Rival Trial Failure Improves The Core TTR Franchise Outlook
Seeking Alpha67 · bullishproduct/pr
S&P 500 Futures Climb in Premarket Trading; Alnylam Pharmaceuticals, BridgeBio Pharma Lead
Barron's73 · bullishgeneral
Pfizer, Alnylam, BridgeBio gain after late-stage trial setback for Astra/ Ionis
Seeking Alpha67 · bullishproduct/pr
What Offers Alnylam Pharmaceuticals (ALNY) Sustained Long-Term Growth?
Yahoo Finance56 · neutralgeneral
Wall Street Thinks This Biotech Stock Can Soar 45%. Here's Why Analysts Are Right.
The Motley Fool73 · bullishanalyst
Komodo Expands Strategic Partnership with Alnylam Pharmaceuticals, Inc. (ALNY)
Yahoo Top56 · neutralproduct/pr
Alnylam Pharmaceuticals, Inc. (ALNY) Discusses ALN-6400 RNAi Therapy Targeting Plasminogen for Rare Bleeding Disorders Transcript
Seeking Alpha56 · neutralproduct/pr
Alnylam Pharmaceuticals, Inc. (ALNY) Discusses ALN-6400 RNAi Therapy Targeting Plasminogen for Rare Bleeding Disorders - Slideshow
Seeking Alpha55 · neutralproduct/pr
Komodo Expands Strategic Partnership With Alnylam to Scale AI-Powered Intelligence Platform | ALNY Stock News
StockTitan63 · neutralproduct/pr
Alnylam Pharmaceuticals, Inc. (ALNY) and GENESIS Pharma Expand Commercial Partnership
Yahoo Top63 · neutralproduct/pr
Alnylam Pharmaceuticals (ALNY), Inceptive Form $2B Partnership to Advance RNAi Drug Discovery
Yahoo Top73 · bullishproduct/pr
Regeneron myasthenia gravis therapy undergoes U.S. and EU review
Seeking Alpha56 · neutralgeneral
Alnylam (ALNY) Expands Its RNAi Therapeutics Reach Into Four More Nordic Countries
Yahoo Top67 · bullishproduct/pr
Alnylam to Host Tenth “RNAi Roundtable” Webcast Series | ALNY Stock News
StockTitan50 · neutralgeneral
Alnylam expands Genesis Pharma collaboration in Europe
Seeking Alpha63 · neutralproduct/pr
Alnylam Pharmaceuticals, Inc. (ALNY) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha55 · neutralgeneral
Alnylam Pharmaceuticals Unveils 2030 Targets, Betting on AMVUTTRA and Pipeline Readouts
Yahoo Top63 · neutralproduct/pr
Bloom Energy, Astera Labs, Alnylam, Reddit Could Be Among Next Adds to S&P 500
Barron's65 · bullishgeneral